| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Wednesday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other
http://feeds.benzinga.com/~r/benzinga/~3/03Y3GeJlftA/teva-vs-amneal-jpmorgan-sees-hope-for-one-decline-for-the-other
Nov 12, 2019 -
It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.
0
Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now?
http://www.zacks.com/stock/news/614175/is-teva-pharmaceutical-industries-ltd-teva-a-great-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-614175
Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Teva launches $1.5B debt offering
https://seekingalpha.com/news/3517269-teva-launches-1_5b-debt-offering?source=feed_news_all
Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y
0
Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase
http://www.zacks.com/stock/news/610241/teva-teva-q3-earnings-miss-stock-up-on-guidance-increase?cid=CS-ZC-FT-analyst_blog|earnings_article-610241
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
0
Teva Pharmaceutical Industries Limited 2019 Q3 - Results - Earnings Call Presentation
https://seekingalpha.com/article/4304322-teva-pharmaceutical-industries-limited-2019-q3-results-earnings-call-presentation?source=feed_tag_israel
Nov 08, 2019 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2019 Q3 earnings call.
0
5 Low Price-to-Book Stocks to Buy in November
http://www.zacks.com/stock/news/609952/5-low-price-to-book-stocks-to-buy-in-november?cid=CS-ZC-FT-analyst_blog|rw-609952
Nov 08, 2019 - P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
0
Teva Pharmaceutical Industries Limited (TEVA) CEO Kare Schultz on Q3 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4303822-teva-pharmaceutical-industries-limited-teva-ceo-kare-schultz-q3-2019-results-earnings-call?source=feed_tag_israel
Nov 07, 2019 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2019 Results Conference Call November 07, 2019 08:00 AM ET Company Participants Kevin Mannix - Senior Vice President of Investor Relations Kare Sc
0
Here's Why Teva Pharmaceuticals Gained 18.5% in October
https://www.fool.com/investing/2019/11/07/heres-why-teva-pharmaceuticals-gained-185-in-octob.aspx?source=iedfolrf0000001
Nov 07, 2019 - Investors grew optimistic that the company's legal and financial risks from the ongoing opioid epidemic may be coming to an end.
0
Teva Pharmaceutical Industries Limited (TEVA) Q3 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2019/11/07/teva-pharmaceutical-industries-limited-teva-q3-201.aspx?source=iedfolrf0000001
Nov 07, 2019 - TEVA earnings call for the period ending September 30, 2019.
0
Teva (TEVA) Q3 Earnings Miss, Sales Top Estimates, Stock Up
http://www.zacks.com/stock/news/608243/teva-teva-q3-earnings-miss-sales-top-estimates-stock-up?cid=CS-ZC-FT-tale_of_the_tape|earnings_report-608243
Nov 07, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. Shares rise in pre-market trading.
0
Page 1>